6,851
Views
145
CrossRef citations to date
0
Altmetric
Reviews

From discovery to licensure, the Adjuvant System story

&
Pages 19-33 | Received 02 May 2016, Accepted 13 Aug 2016, Published online: 21 Nov 2016

Figures & data

Figure 1. Evolution of knowledge and tools in immunology. Cr release assay = chromium release assay, MHC = major histocompatibility complex, Treg = T-regulatory cells, TLR = toll-like receptors, NLR = NOD-like receptors.

Figure 1. Evolution of knowledge and tools in immunology. Cr release assay = chromium release assay, MHC = major histocompatibility complex, Treg = T-regulatory cells, TLR = toll-like receptors, NLR = NOD-like receptors.

Figure 2. Adjuvant Systems: key developmental milestones. POC = proof of concept.

Figure 2. Adjuvant Systems: key developmental milestones. POC = proof of concept.

Table 1. GSK's Adjuvant Systems.

Table 2. Impact of composition on the physical properties of oil-in-water emulsions (a subset of more than 60 tested formulations). Key requirements were stability over time after freeze/thaw, and sterile filterability (<200 nm). Shaded area represents the selected emulsion known as AS03.

Figure 3. Lytic action of QS-21 is abrogated in cholesterol-based liposomes.

Figure 3. Lytic action of QS-21 is abrogated in cholesterol-based liposomes.

Figure 4. General mode of action of an adjuvant (adapted fromCitation104).

Figure 4. General mode of action of an adjuvant (adapted fromCitation104).